Keywords: pfizer, starts, ph, iii, trials, tlc-d99, phase

Pfizer Starts Ph III Trials Of TLC-D99

Article | 19 December 1994

Print This

Two Phase III clinical trials in breast cancer patients have begun with TLC-D99 (liposomal doxorubicin), a product being jointly developed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in